Chargement en cours...
PET of HER2-Positive Pulmonary Metastases with (18)F-Z(HER2:342) Affibody in a Murine Model of Breast Cancer: Comparison with (18)F-FDG
Targeted therapies often depend on the expression of the target present in the tumor. This expression can be difficult to ascertain in widespread metastases. (18)F-FDG PET/CT, although sensitive, is nonspecific for particular tumor markers. Here, we compare the use of a human epidermal growth factor...
Enregistré dans:
| Publié dans: | J Nucl Med |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497802/ https://ncbi.nlm.nih.gov/pubmed/22582046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.100354 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|